Abstract
This chapter outlines the Economical, Clinical, and Humanistic Outcomes (ECHO) model as a framework for the multidimensional classification of outcomes . Moving on from the traditional disease-oriented model, the ECHO model ensures that economic and humanistic measures are evaluated, as well as clinical variables. Consideration of all three outcome types is important when evaluating pharmaceutical care interventions through well-designed, rigorous trials.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rademakers J, Delnoij D, de Boer D. Structure, process or outcome: which contributes most to patients” overall assessment of healthcare quality? BMJ Qual Saf. 2011;20(4):326–31.
Kozma CM, Reeder CE, Schulz RM. Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther. 1993;15(6):1121–32.
Kozma CM. Outcomes research and pharmacy practice. Am Pharm. 1995;NS35(7):35–41.
Gunter MJ. The role of the ECHO model in outcomes research and clinical practice improvement. Am J Manage Care. 1999;5(4):S217–24.
Heneghan C, Goldacre B, Mahtani KR. Why clinical trial outcomes fail to translate into benefits for patients. Trials. 2017;18:122.
Epstein RS, Sherwood LM. From outcomes research to disease management: a guide for the perplexed. Ann Intern Med. 1996;124(9):832–7.
Kattan MW. ed. 2009. The Encyclopedia of medical decision making, Vol. 1. Washington, DC: SAGE Publications.
Velentegas P, Dreyer NA, Wu AW. 2013. Outcome definition and measurement. In: Velentegas P, Dreyer NA, Nourjah P, Smith SR, Torchia MM, editors. Developing a protocol for observational comparative effectiveness research: a user”s guide. Rockville, MD: Agency for Healthcare Research and Quality.
Siaw MYL, Ko Y, Malone DC, Tsou KYK, Lew YJ, Foo D, Tan E, Chan SC, Chia A, Sinaram SS, Goh KC, Lee JYC. Impact of pharmacist-involved collaborative care on the clinical, humanistic and cost outcomes of high-risk patients with type 2 diabetes (IMPACT): a randomized controlled trial. J Clin Pharm Ther. 2017;42(4):475–82.
Bernsten C, Björkman I, Caramona M, Crealey G, Frøkjӕr F, Grundberger E, Gustafsson T, Henman M, Herborg H, Hughes C, McElnay J, Magner M, van Mil F, Schaeffer M, Silva S, Søndergaard B, Sturgess I, Tromp D, Vivero L, Winterstein A. Pharmaceutical care of the Elderly in Europe Research (PEER) Group. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care. Drugs Aging. 2001;18(1): 63–77.
Cordina M, McElnay JC, Hughes CM. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy. 2001;21(10):1196–203.
Sadik A, Yousif M, McElnay JC. Pharmaceutical care of patients with heart failure. Br J Clin Pharmacol. 2005;60(2):183–93.
Sturgess IK, McElnay JC, Hughes CM, Crealey G. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci. 2003;25(5):218–26.
Ramalho de Oliveira D, Brummel AR, Miller DB. Medication therapy management: 10 years of experience in a large integrated healthcare system. J Manage Care Pharm. 2010;16(3):185–95.
Singhal PK, Raisch DW, Gupchup GV. The impact of in community and ambulatory care settings: evidence and recommendations for future research. Ann Pharmacother. 1999;33(12):1336–55.
Cheng Y, Raisch DW, Borrego ME, Gupchup GV. Economic, clinical, and humanistic outcomes (ECHOs) of pharmaceutical care services for minority patients: a literature review. Res Social Adm Pharm. 2013;9(3):311–29.
Hill-Taylor B, Sketris I, Hayden J, O”Sullivan D, Christie R. Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther. 2013;38(5):360–72.
Ganguli A, Clewell J, Shillington AC. The impact of patient support programs on adherence, clinical, humanistic, and economic patient outcomes: a targeted systematic review. Patient Prefer Adherence. 2016;10:711–25.
Loh ZWR, Cheen MHH, Wee HL. Humanistic and economic outcomes of pharmacist-provided medication review in the community-dwelling elderly: a systematic review and meta-analysis. J Clin Pharm Ther. 2016;41(6):621–33.
Meid AD, Lampbert A, Burnett A, Seidling HM, Haefeli WE. The impact of pharmaceutical care interventions for medication underuse in older people: a systematic review and meta-analysis. Br J Clin Pharmacol. 2015;80(4):768–76.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Barry, H.E., Hughes, C.M. (2019). Economical, Clinical, and Humanistic Outcomes and Pharmaceutical Care. In: Alves da Costa, F., van Mil, J., Alvarez-Risco, A. (eds) The Pharmacist Guide to Implementing Pharmaceutical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-92576-9_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-92576-9_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-92575-2
Online ISBN: 978-3-319-92576-9
eBook Packages: MedicineMedicine (R0)